Q32BIO ADX-914-202 This is a phase IIa, randomized, double-blind, placebo-controlled, multi-center proof-of-concept (POC) study in subjects with moderate to severe Atopic Dermatitis.
Volunteers needed for up to a 28 week long clinical trial with up to 13 office visits for an investigational product. $100.00 stipend available for each office visit completed.
To Qualify, you must meet the following INCLUSION CRITERIA:
1.) 18+ years of age
2.) Have MODERATE to SEVERE eczema (atopic dermatitis)
3.) Minimum of 10% eczema affected body surface area
To Qualify, you must NOT meet the following EXCLUSION CRITERIA:
1.) Weight over 264 lbs at your 1st office visit.
2.) Unwilling to discontinue current atopic dermatitis treatments
3.) Female who is pregnant or breastfeeding
ClinicalTrials.gov Identifier: NCT 05509023
https://clinicaltrials.gov/ct2/show/NCT05509023?term=q32+bio&draw=2&rank=1
q32 bio logo for ADX-914-202 trial
We love our patients, so feel free to visit during normal business hours.
510 S Cowley Spokane, WA 99202
Mon | 09:00 am – 05:00 pm | |
Tue | 09:00 am – 05:00 pm | |
Wed | 09:00 am – 05:00 pm | |
Thu | 09:00 am – 05:00 pm | |
Fri | 09:00 am – 05:00 pm | |
Sat | Closed | |
Sun | Closed |
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.